Nmblr Edge - Define What Sets You Apart

Use Nmblr Edge to differentiate your brand, creating a competitive position that resonates with target audiences and aligns with business goals.

Defining what sets you apart is one of twelve strategic moves that Nmblr supports through the tool Nmblr Edge.
Nmblr Edge addresses the challenge of differentiating a brand by systematically establishing a strategic competitive position that resonates with target audiences and aligns with the winning focus.
This process is critical for ensuring commercial viability, driving customer preference, and avoiding commoditisation.

The problems solved by this move

Traditional positioning often fails because:

Undifferentiated offerings blend into market noise, making brands interchangeable.
Misaligned value propositions waste resources on features customers don’t prioritise - i.e. they don’t create meaningful value.
Static strategies become obsolete as markets evolve or competitors adapt.

This six-step 'move' provides a structured framework to:

Diagnose market gaps and customer needs.
Define the ‘space’ that you will occupy that aligns with the ‘winning focus’.
Embed the positioning across operations to sustain competitive advantage.

Why competitive positioning aligned to a 'Winning Focus' matters

Guides resource allocation: Directs R&D, marketing, and commercial investments toward areas of maximum impact (e.g., optimising clinical endpoints that matter most to prescribers).
Prevents commoditisation: In crowded markets (e.g., oncology), even marginal efficacy improvements may not suffice unless paired with an understanding of the value this creates.
Builds stakeholder consensus: Aligns internal teams (clinical, regulatory, commercial) around a unified data/information strategy, reducing conflicting priorities.

How Positioning Informs Strategic Decisions

Clinical development:
- Shapes trial design (e.g., selecting comparators, endpoints) to validate what we aspire to stand for.
- Informs target product profiles (TPPs) and regulatory pathways.
Commercialisation:
- Drives messaging.
- Influences pricing (premium vs. value-based) and market access strategies ie the value proposition needs to align to the positioning decision.
Lifecycle management:
- Guides post-launch studies for label expansions or new indications, formulations, dosing and other life cycle management initiatives.

When to revisit positioning

During clinical development:
- Preclinical/Phase I: Align positioning with early TPP assumptions.
- Phase II: Refine based on KOL feedback and competitor landscape shifts.
- Phase III: Validate with phase 3 data/ real-world data and payer insights.
Post-launch:
- Market entry: To adjust messaging if initial adoption lags.
- Competitor moves: Respond to new entrants or generic threats by emphasising unique benefit.
- Pipeline expansions: Reassess positioning when adding indications or combination therapies.

Critical success factors

Early integration: Begin positioning work in Phase I/II to inform trial design and avoid costly pivots.
Cross-functional alignment: Ensure clinical, commercial, and regulatory teams share a unified vision.
Continuous monitoring: Detect shifts or new information requiring repositioning.